<DOC>
	<DOCNO>NCT02126800</DOCNO>
	<brief_summary>Treatment breast cancer traditionally base primary tumour 's feature breast . Only recently , cancer return site , attempt biopsy metastatic disease change treatment accordingly . A 'repeat biopsy ' technically difficult , painful , possible , represent small sample one many metastasis . Even one deposit respond new treatment , neighbour one may continue grow . There urgent need characterise deposit , particularly lethal one progress despite treatment . This study enable comprehensive analysis metastatic process evolution breast cancer course treatment . Patients consent life donate tissue molecular analysis provide mean analysis . Main aim : - To comprehensively systematically examine metastatic breast cancer detail exploratory molecular characterization elucidate possible inter- intratumoural heterogeneity primary tumour majority metastatic site . - To map natural history metastatic breast cancer process</brief_summary>
	<brief_title>Rapid Medical Donation Programme Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patients complete active treatment ( trial ) metastatic breast cancer . Patients refer either community hospitalbased palliative care unit Royal Marsden National Health Service Foundation Trust . Lack capacity / inability give inform consent . Diagnosis alternative cancer within last 5 year resect basal cell skin cancer cervical intraepithelial neoplasia . Patients know HIV , Hepatitis B virus Hepatitis C virus positive serology . Spongiform encephalopathy ( know suspect CJD ) . Eligibility current participation clinical trial ( exclude palliative care trial )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>breast cancer</keyword>
</DOC>